{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:49:25Z","timestamp":1790264965936,"version":"4.1.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Randomized controlled trials (RCTs) remain the cornerstone of causal inference on the safety and efficacy of medicinal products. But their limited follow-up, controlled settings, and narrowly defined data collection to balance the burden to patients and maintain study feasibility often results in unaddressed important questions for health authorities and other clinical decision makers. Linkage of RCT data to routinely collected health data [real-world data (RWD)] offers a mechanism for addressing these gaps by extending observations and outcomes assessment into routine practice. This paper synthesizes methodological and operational considerations for RCTs with RWD linkage, drawing on deterministic, probabilistic, referential, and privacy-preserving record linkage methodologies and on four case studies that span different indications and regional settings: a long-term follow-up of a human papillomavirus vaccine trial using deterministic linkage via universal Personal Identity Numbers; a U.S. linkage of a respiratory syncytial virus vaccine trial to administrative health claims using privacy-preserving tokenization; and two transcatheter aortic valve replacement trials linked to Medicare claims to reproduce randomized treatment-effect estimates and to assess transportability to the broader Medicare population. We offer actionable methodological considerations and recommendations, drawing on the case studies and the broader linkage literature. Progress beyond the current state will require global health authority guidance specific to linking clinical trials with routinely collected data, shared benchmarks for evaluating linkage approaches, routine reporting and assessments of impact of use cases on regulatory and reimbursement decisions. Linkage of clinical trial data with routinely collected data sources can meaningfully accelerate clinical development and inform health authority and other clinical decision making.<\/jats:p>","DOI":"10.3389\/fphar.2026.1887249","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T09:52:51Z","timestamp":1786096371000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Linking clinical trial data with real-world data for enhanced clinical evidence generation: methodological considerations and recommendations"],"prefix":"10.3389","volume":"17","author":[{"given":"Anna-Katharina","family":"Meinecke","sequence":"first","affiliation":[{"name":"Bayer AG","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Diaz-Decaro","sequence":"additional","affiliation":[{"name":"ModernaTX, Inc.","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Gavin","sequence":"additional","affiliation":[{"name":"Datavant, Inc.","place":["Phoenix, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Sun","sequence":"additional","affiliation":[{"name":"ModernaTX, Inc.","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan B.","family":"Strom","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Soriano Gabarr\u00f3","sequence":"additional","affiliation":[{"name":"Independent Researcher","place":["Potsdam, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[{"name":"Neurocrine Biosciences","place":["San Diego, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana Y.","family":"Teltsch","sequence":"additional","affiliation":[{"name":"EviDT LLC","place":["Lexington, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Najafzadeh","sequence":"additional","affiliation":[{"name":"UCB, Inc","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Panozzo","sequence":"additional","affiliation":[{"name":"ModernaTX, Inc.","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pareen","family":"Vora","sequence":"additional","affiliation":[{"name":"Bayer AG","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Burcu","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc.","place":["Rahway, NJ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"B1","unstructured":"Data privacy in the digital age: a comparative analysis of U.S. and EU regulations\n          \n          \n            \n              Aidun\n              E.\n            \n          \n          \n          2025"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1001319","article-title":"Ethical considerations in informed consent","volume-title":"Ethics - Scientific Research, Ethical Issues, Artificial Intelligence and Education","author":"Arellano","year":"2023"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e71272","DOI":"10.1002\/hsr2.71272","article-title":"Combining real-world and clinical trial data through privacy-preserving record linkage: opportunities and Challenges\u2014A narrative review","volume":"8","author":"Batech","year":"2025","journal-title":"Health Sci. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/pds.4297","article-title":"Good practices for real-world data studies of treatment And\/Or comparative effectiveness: recommendations from the joint ISPOR-ISPE special task force on real-world evidence in health care decision making","volume":"26","author":"Berger","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1055\/a-1910-4154","article-title":"Real-world matching performance of deidentified record-linking tokens","volume":"13","author":"Bernstam","year":"2022","journal-title":"Appl. Clin. Inf."},{"key":"B6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/picr.picr_12_23","article-title":"Data quality - the foundation of real-world studies","volume":"14","author":"Bhatt","year":"2023","journal-title":"Perspect. Clin. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/1472-6963-10-346","article-title":"Data linkage: a powerful research tool with potential problems","volume":"10","author":"Bohensky","year":"2010","journal-title":"BMC Health Serv. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s43441-021-00322-8","article-title":"A framework for extension studies using real-world data to examine long-term safety and effectiveness","volume":"56","author":"Burcu","year":"2022","journal-title":"Ther. Innovation and Regul. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMsb1610128","article-title":"Transforming evidence generation to support health and health care decisions","volume":"375","author":"Califf","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1056\/NEJMp2200089","article-title":"Real-world evidence where are we now?","volume":"386","author":"Concato","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40290-022-00456-6","article-title":"Real-World evidence: a primer","volume":"37","author":"Dang","year":"2023","journal-title":"Pharm. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1146\/annurev-statistics-042522-103837","article-title":"A review of generalizability and transportability","volume":"10","author":"Degtiar","year":"2023","journal-title":"Annu. Rev. Statistics Its Appl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.23889\/ijpds.v3i1.410","article-title":"Demystifying probabilistic linkage: common myths and misconceptions","volume":"3","author":"Doidge","year":"2018","journal-title":"Int. J. Popul. Data Sci."},{"key":"B15","volume-title":"Linking data for health services research: a framework and instructional guide.","author":"Dusetzina","year":"2014"},{"key":"B16","doi-asserted-by":"publisher","first-page":"101354","DOI":"10.1016\/j.conctc.2024.101354","article-title":"Linking clinical trial participants to their U.S. real-world data through tokenization: a practical guide","volume":"41","author":"Eckrote","year":"2024","journal-title":"Contemp. Clin. Trials Commun."},{"key":"B17","unstructured":"Reflection paper on the use of real-world data in non-interventional studies to generate real-world evidence for regulatory purposes\n          \n          \n          2025"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105996","DOI":"10.1016\/j.cct.2020.105996","article-title":"Use of real-world data for HPV vaccine trial follow-up in the nordic region","volume":"92","author":"Enerly","year":"2020","journal-title":"Contemp. Clin. Trials"},{"key":"B19","unstructured":"Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products\n          \n          \n          2023"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.14283\/jpad.2024.115","article-title":"Alzheimer's disease linkage to real-world evidence (ad-line) study: linking claims data to phase 3 graduate study of gantenerumab","volume":"11","author":"Fillit","year":"2024","journal-title":"J. Prev. Alzheimer's Dis."},{"key":"B21","unstructured":"Findata- Finnish social and health data permit authority\n          \n          \n          2025"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/jamia\/ocac068","article-title":"Evaluation of real-world referential and probabilistic patient matching to advance patient identification strategy","volume":"29","author":"Grannis","year":"2022","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S2589-7500(21)00081-9","article-title":"Ethnic bias in data linkage","volume":"3","author":"Grath-Lone","year":"2021","journal-title":"Lancet Digital Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e000087","DOI":"10.1136\/bmjmed-2021-000087","article-title":"Data linkage in medical research","volume":"1","author":"Harron","year":"2022","journal-title":"BMJ Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12874-017-0306-8","article-title":"Utilising identifier error variation in linkage of large administrative data sources","volume":"17","author":"Harron","year":"2017","journal-title":"BMC Med. Res. Methodol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1740774518815653","article-title":"Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes","volume":"16","author":"Hay","year":"2019","journal-title":"Clin. Trials"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e70117","DOI":"10.1002\/pds.70117","article-title":"Real-world data and real-world evidence in regulatory decision making: report summary from the council for international organizations of medical sciences (cioms) working group XIII","volume":"34","author":"Hennessy","year":"2025","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B28","unstructured":"E6(R3) good clinical practice\n          \n          \n          2025"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0000515","DOI":"10.1371\/journal.pdig.0000515","article-title":"Outlier analysis for accelerating clinical discovery: an augmented intelligence framework and a systematic review","volume":"3","author":"Janoudi","year":"2024","journal-title":"PLOS Digit. Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13104-022-06243-5","article-title":"Establishing a framework for privacy-preserving record linkage among electronic health record and administrative claims databases within PCORnet(\u00ae), the National Patient-Centered Clinical Research network","volume":"15","author":"Kiernan","year":"2022","journal-title":"BMC Res. Notes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"n857","DOI":"10.1136\/bmj.n857","article-title":"CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration","volume":"373","author":"Kwakkenbos","year":"2021","journal-title":"Bmj"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/jamia\/ocaa340","article-title":"Quality assessment of real-world data repositories across the data life cycle: a literature review","volume":"28","author":"Liaw","year":"2021","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/jamia\/ocac229","article-title":"Assessing the impact of privacy-preserving record linkage on record overlap and patient demographic and clinical characteristics in PCORnet\u00ae, the National Patient-Centered Clinical Research Network","volume":"30","author":"Marsolo","year":"2023","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B34","unstructured":"Real-world data quality: what are the opportunities and challenges?\n          \n          \n          2023"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e257797","DOI":"10.1001\/jamanetworkopen.2025.7797","article-title":"Linkage of clinical trial data to routinely collected data sources: a scoping review","volume":"8","author":"NajafZadeh","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"B36","volume-title":"Medtronic Corevalve\u00ae U.S. Pivotal Trial","year":"2010"},{"key":"B37","volume-title":"Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)","year":"2012"},{"key":"B38","volume-title":"Transcatheter Aortic Valve Replacement with the Medtronic Transcatheter Aortic Valve Replacement System in Patients at Low Risk for Surgical Aortic Valve Replacement","year":"2016"},{"key":"B39","volume-title":"A Phase 2\/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults \u226560 Years of Age","year":"2021"},{"key":"B40","volume-title":"mRNA-1345-P901 Study: RSV Outcomes Study Extension","year":"2022"},{"key":"B45","volume-title":"All of Us Data Browser.","year":"2024"},{"key":"B41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/jamia\/ocz232","article-title":"A hybrid approach to record linkage using a combination of deterministic and probabilistic methodology","volume":"27","author":"Ong","year":"2020","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1093\/jamia\/ocae248","article-title":"Linkability measures to assess the data characteristics for record linkage","volume":"31","author":"Ong","year":"2024","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1093\/jamia\/ocae196","article-title":"Privacy preserving record linkage for public health action: opportunities and challenges","volume":"31","author":"Pathak","year":"2024","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B10","volume-title":"Act on the Protection of Personal Information (APPI)","year":"2022"},{"key":"B44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pds.4924","article-title":"Data linkage in pharmacoepidemiology: a call for rigorous evaluation and reporting","volume":"29","author":"Pratt","year":"2020","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/pds.4918","article-title":"Linking electronic health data in pharmacoepidemiology: appropriateness and feasibility","volume":"29","author":"Rivera","year":"2020","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/jamia\/ocaa224","article-title":"Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review","volume":"28","author":"Rogers","year":"2021","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1172\/jci129197","article-title":"Opportunities and challenges in using real-world data for health care","volume":"130","author":"Rudrapatna","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1786017","DOI":"10.3389\/fphar.2026.1786017","article-title":"Bridging evidence worlds: policy and practice pathways for integrating clinical trials and real-world data in drug development and HTA [Policy and Practice Reviews]","volume":"17","author":"Sagkriotis","year":"2026","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5334\/ijic.5687","article-title":"Integrated health and social care in the United States: a decade of policy progress","volume":"21","author":"Sandhu","year":"2021","journal-title":"Int. J. Integr. Care"},{"key":"B51","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/ije\/dyv322","article-title":"Probabilistic record linkage","volume":"45","author":"Sayers","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ahj.2019.02.007","article-title":"Validating the use of registries and claims data to support randomized trials: rationale and design of the extending trial-based evaluations of medical therapies using novel sources of data (EXTEND) study","volume":"212","author":"Strom","year":"2019","journal-title":"Am. Heart J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/cpt.70033","article-title":"Clinical trials with pragmatic elements: a review of use cases and real-world data utilization","volume":"118","author":"Su","year":"2025","journal-title":"Clin. Pharmacol. and Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"ooaf002","DOI":"10.1093\/jamiaopen\/ooaf002","article-title":"Accuracy of privacy preserving record linkage for real world data in the United States: a systemic review","volume":"8","author":"Tyagi","year":"2025","journal-title":"JAMIA Open"},{"key":"B55","volume-title":"UK Biobank Research Analysis Platform","year":"2025"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jbi.2015.05.012","article-title":"When to conduct probabilistic linkage vs. deterministic linkage? A simulation study","volume":"56","author":"Zhu","year":"2015","journal-title":"J. Biomed. Inf."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1887249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T09:52:55Z","timestamp":1786096375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1887249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":57,"alternative-id":["10.3389\/fphar.2026.1887249"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1887249","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"1887249"}}